GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Labcorp Holdings Inc (FRA:N6B) » Definitions » EV-to-FCF

Labcorp Holdings (FRA:N6B) EV-to-FCF : 34.76 (As of May. 21, 2024)


View and export this data going back to 1991. Start your Free Trial

What is Labcorp Holdings EV-to-FCF?

EV-to-FCF is calculated as enterprise value divided by its free cash flow. As of today, Labcorp Holdings's Enterprise Value is €21,433 Mil. Labcorp Holdings's Free Cash Flow for the trailing twelve months (TTM) ended in Mar. 2024 was €617 Mil. Therefore, Labcorp Holdings's EV-to-FCF for today is 34.76.

The historical rank and industry rank for Labcorp Holdings's EV-to-FCF or its related term are showing as below:

FRA:N6B' s EV-to-FCF Range Over the Past 10 Years
Min: 9.51   Med: 18.66   Max: 50.87
Current: 35.39

During the past 13 years, the highest EV-to-FCF of Labcorp Holdings was 50.87. The lowest was 9.51. And the median was 18.66.

FRA:N6B's EV-to-FCF is ranked worse than
63.54% of 96 companies
in the Medical Diagnostics & Research industry
Industry Median: 28.11 vs FRA:N6B: 35.39

EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

As of today (2024-05-21), Labcorp Holdings's stock price is €192.50. Labcorp Holdings's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2024 was €4.603. Therefore, Labcorp Holdings's PE Ratio for today is 41.82.


Labcorp Holdings EV-to-FCF Historical Data

The historical data trend for Labcorp Holdings's EV-to-FCF can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Labcorp Holdings EV-to-FCF Chart

Labcorp Holdings Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
EV-to-FCF
Get a 7-Day Free Trial Premium Member Only Premium Member Only 20.01 12.83 11.16 15.57 28.03

Labcorp Holdings Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
EV-to-FCF Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 17.56 19.95 22.33 28.03 36.41

Competitive Comparison of Labcorp Holdings's EV-to-FCF

For the Diagnostics & Research subindustry, Labcorp Holdings's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Labcorp Holdings's EV-to-FCF Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Labcorp Holdings's EV-to-FCF distribution charts can be found below:

* The bar in red indicates where Labcorp Holdings's EV-to-FCF falls into.



Labcorp Holdings EV-to-FCF Calculation

Labcorp Holdings's EV-to-FCF for today is calculated as:

EV-to-FCF=Enterprise Value (Today)/Free Cash Flow (TTM)
=21432.578/616.508
=34.76

Labcorp Holdings's current Enterprise Value is €21,433 Mil.
Labcorp Holdings's Free Cash Flow for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was €617 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Labcorp Holdings  (FRA:N6B) EV-to-FCF Explanation

EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

Labcorp Holdings's PE Ratio for today is calculated as:

PE Ratio=Share Price (Today)/Earnings per Share (Diluted) (TTM)
=192.50/4.603
=41.82

Labcorp Holdings's share price for today is €192.50.
Labcorp Holdings's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was €4.603.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.


Labcorp Holdings EV-to-FCF Related Terms

Thank you for viewing the detailed overview of Labcorp Holdings's EV-to-FCF provided by GuruFocus.com. Please click on the following links to see related term pages.


Labcorp Holdings (FRA:N6B) Business Description

Traded in Other Exchanges
Address
358 South Main Street, Burlington, NC, USA, 27215
Laboratory Corp. of America is one of the nation's two largest independent clinical laboratories, with roughly 20% of the independent lab market. The company operates approximately 2,000 patient-service centers, offering a broad range of 5,000 clinical lab tests, ranging from routine blood and urine screens to complex oncology and genomic testing.

Labcorp Holdings (FRA:N6B) Headlines

No Headlines